Louis Manzo - Net Worth and Insider Trading

Louis Manzo Net Worth

The estimated net worth of Louis Manzo is at least $383,611 dollars as of 2024-04-23. Louis Manzo is the Director of Capricor Therapeutics Inc and owns about 77,654 shares of Capricor Therapeutics Inc (CAPR) stock worth over $383,611. Details can be seen in Louis Manzo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Louis Manzo has not made any transactions after 2017-05-09 and currently still holds the listed stock(s).

Transaction Summary of Louis Manzo

To

Louis Manzo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Louis Manzo owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .

Click here to see the complete history of Louis Manzo’s form 4 insider trades.

Insider Ownership Summary of Louis Manzo

Ticker Comapny Transaction Date Type of Owner
CAPR Capricor Therapeutics Inc 2019-12-17 director

Louis Manzo Latest Holdings Summary

Louis Manzo currently owns a total of 1 stock. Louis Manzo owns 77,654 shares of Capricor Therapeutics Inc (CAPR) as of May 9, 2017, with a value of $383,611.

Latest Holdings of Louis Manzo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAPR Capricor Therapeutics Inc 2017-05-09 77,654 4.94 383,611

Holding Weightings of Louis Manzo


Louis Manzo Form 4 Trading Tracker

According to the SEC Form 4 filings, Louis Manzo has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 1,000 shares on May 9, 2017, which cost Louis Manzo around $31,000.

Insider Trading History of Louis Manzo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Louis Manzo Trading Performance

GuruFocus tracks the stock performance after each of Louis Manzo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis Manzo is 14.49%. GuruFocus also compares Louis Manzo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis Manzo within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Louis Manzo's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Louis Manzo

Average Return

-12.1%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -23.33 14.49 9.51 -12.1 -38.47 -39.38
Relative Return to S&P 500(%) -25.37 11.63 2.83 -27.11 -51.45 -48.67

Louis Manzo Ownership Network

Ownership Network List of Louis Manzo

No Data

Ownership Network Relation of Louis Manzo


Louis Manzo Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Louis Manzo is the director of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .

Capricor Therapeutics Inc (CAPR) Insider Trades Summary

Over the past 18 months, Louis Manzo made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net sale of 17,772 shares made by Xavier Avat , and a net purchase of 10,000 shares made by Collier Earl M Jr .

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,772 shares of Capricor Therapeutics Inc (CAPR) were sold and 22,993 shares were bought by its insiders, resulting in a net purchase of 5,221 shares.

Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Capricor Therapeutics Inc Insider Transactions

No Available Data

Louis Manzo Mailing Address

Above is the net worth, insider trading, and ownership report for Louis Manzo. You might contact Louis Manzo via mailing address: C/o Capricor Therapeutics, Inc., 8840 Wilshire Blvd., 2nd Floor, Beverly Hills Ca 90211.

Discussions on Louis Manzo

No discussions yet.